AstraZeneca launches $1.5 billion cost-saving plan to fund growth, says no layoffs expected

AstraZeneca announced a three-year cost‑saving initiative worth $1.5 billion during its third‑quarter earnings call.

The program, called Reshaping for Sustainable Growth, aims to redeploy resources across the pipeline and globally, focusing on upskilling, reskilling and hiring new talent rather than cutting jobs.

Executives said the savings will create capacity to support expected growth, and the company plans to use technology and efficiency measures to achieve the targets.

CFO Aradhana Sarin emphasized that the effort is about reshaping the organization, not shrinking it, with an initial cost of $2 billion and projected savings of $1.5 billion.